• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高亲和力肝素与抗凝血酶III的结合。结合相互作用的停流动力学研究。

Binding of high affinity heparin to antithrombin III. Stopped flow kinetic studies of the binding interaction.

作者信息

Olson S T, Srinivasan K R, Björk I, Shore J D

出版信息

J Biol Chem. 1981 Nov 10;256(21):11073-9.

PMID:7287752
Abstract

The kinetics of high affinity heparin binding to human antithrombin III has been studied by stopped flow fluorimetry, using the 40% antithrombin fluorescence enhancement resulting from this interaction. At mu 0.15, pH 7.4, and 25 degrees C, the observed pseudo-first order rate constant varies hyperbolically with heparin concentration with a limiting rate constant of 440 +/- 90 s-1, demonstrating that heparin binding is a two-step process involving a conformational change in antithrombin III. An identical dependence is produced when antithrombin is varied, consistent with a symmetrical mechanism in which heparin binding induces a conformational change in antithrombin rather than perturbing an equilibrium between two conformational states of the protein. The rate constant for dissociation of the antithrombin-heparin complex is 1.1-1.5 s-1 at mu 0.15, as determined from the ordinate intercept at low heparin concentrations or by dissociation of the antithrombin-heparin complex with iodide. Observation of a single pseudo-first order binding rates over a 400-fold heparin concentration range with no detectable lags is compatible with the initial binding step being in rapid equilibrium with a KD of 4.3 +/- 1.3 X 10(-5) M at mu 0.15. Variation in ionic strength primarily affects the KD for the initial binding step with little effect on the conformational change rate constants, implying that binding involves ionic interactions. Calculation of the overall dissociation equilibrium constant from these rate parameters agrees with the directly determined value of 7.2 +/- 1.9 X 10(-8) M at mu 0.15. A major function of the conformational change is, thus, to increase the affinity of heparin for antithrombin III greater than 300-fold. The implications of these findings for the mechanism of the heparin-catalyzed inhibition of coagulation proteases by antithrombin III are discussed.

摘要

利用高亲和力肝素与人抗凝血酶III相互作用引起的40%抗凝血酶荧光增强,通过停流荧光法研究了高亲和力肝素与人抗凝血酶III结合的动力学。在μ0.15、pH 7.4和25℃条件下,观察到的伪一级速率常数随肝素浓度呈双曲线变化,极限速率常数为440±90 s-1,表明肝素结合是一个两步过程,涉及抗凝血酶III的构象变化。当改变抗凝血酶时也会产生相同的依赖性,这与一种对称机制一致,即肝素结合诱导抗凝血酶的构象变化,而不是扰乱蛋白质两种构象状态之间的平衡。在μ0.15时,抗凝血酶-肝素复合物的解离速率常数为1.1-1.5 s-1,这是通过低肝素浓度下的纵坐标截距或用碘化物解离抗凝血酶-肝素复合物来确定的。在400倍肝素浓度范围内观察到单一的伪一级结合速率且无明显滞后现象,这与初始结合步骤处于快速平衡状态相符,在μ0.15时KD为4.3±1.3×10(-5) M。离子强度的变化主要影响初始结合步骤的KD, 对构象变化速率常数影响很小,这意味着结合涉及离子相互作用。根据这些速率参数计算的总解离平衡常数与在μ0.15时直接测定的7.2±1.9×10(-8) M值一致。因此,构象变化的一个主要功能是使肝素对抗凝血酶III的亲和力增加300倍以上。讨论了这些发现对肝素催化抗凝血酶III抑制凝血蛋白酶机制的意义。

相似文献

1
Binding of high affinity heparin to antithrombin III. Stopped flow kinetic studies of the binding interaction.高亲和力肝素与抗凝血酶III的结合。结合相互作用的停流动力学研究。
J Biol Chem. 1981 Nov 10;256(21):11073-9.
2
Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. Characterization of assembly, product formation, and heparin dissociation steps in the factor Xa reaction.抗凝血酶III催化的肝素对蛋白酶失活的瞬态动力学。凝血因子Xa反应中组装、产物形成和肝素解离步骤的表征。
J Biol Chem. 1989 Apr 5;264(10):5452-61.
3
Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.抗凝血酶结合五糖在肝素加速抗凝血酶-蛋白酶反应中的作用。解析抗凝血酶构象变化对肝素加速反应速率的贡献。
J Biol Chem. 1992 Jun 25;267(18):12528-38.
4
Neutralization and binding of heparin by S protein/vitronectin in the inhibition of factor Xa by antithrombin III. Involvement of an inducible heparin-binding domain of S protein/vitronectin.抗凝血酶III抑制因子Xa过程中S蛋白/玻连蛋白对肝素的中和及结合作用。S蛋白/玻连蛋白诱导型肝素结合结构域的参与。
J Biol Chem. 1987 Sep 5;262(25):12247-53.
5
Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. Linkage of protease-inhibitor-heparin interactions in the reaction with thrombin.
J Biol Chem. 1988 Feb 5;263(4):1698-708.
6
The oligosaccharide side chain on Asn-135 of alpha-antithrombin, absent in beta-antithrombin, decreases the heparin affinity of the inhibitor by affecting the heparin-induced conformational change.α-抗凝血酶Asn-135位点上的寡糖侧链(β-抗凝血酶中不存在)通过影响肝素诱导的构象变化降低了该抑制剂对肝素的亲和力。
Biochemistry. 1997 Jun 3;36(22):6682-91. doi: 10.1021/bi9702492.
7
Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. The reaction step limiting heparin turnover in thrombin neutralization.
J Biol Chem. 1986 Oct 5;261(28):13151-9.
8
The heparin-enhanced antithrombin III/thrombin reaction is saturable with respect to both thrombin and antithrombin III.肝素增强的抗凝血酶III/凝血酶反应对于凝血酶和抗凝血酶III而言都是可饱和的。
J Biol Chem. 1982 Dec 10;257(23):13899-302.
9
Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence.
Biochim Biophys Acta. 1977 Jan 25;490(1):104-11. doi: 10.1016/0005-2795(77)90110-6.
10
Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites.肝素激活抗凝血酶的机制:支持变构激活诱导契合模型的证据,该模型涉及两个相互作用亚位点。
Biochemistry. 1998 Sep 15;37(37):13033-41. doi: 10.1021/bi981426h.

引用本文的文献

1
NMR Characterization of the Interactions Between Glycosaminoglycans and Proteins.糖胺聚糖与蛋白质相互作用的核磁共振表征
Front Mol Biosci. 2021 Mar 16;8:646808. doi: 10.3389/fmolb.2021.646808. eCollection 2021.
2
Comprehensive Landscape of Heparin Therapy for COVID-19.肝素治疗 COVID-19 的全面概况。
Carbohydr Polym. 2021 Feb 15;254:117232. doi: 10.1016/j.carbpol.2020.117232. Epub 2020 Oct 22.
3
Mechanisms of ligand binding.配体结合机制。
Biophys Rev (Melville). 2020 Dec;1(1):011303. doi: 10.1063/5.0020997.
4
Retention of beneficial molecules and coagulation factors during haemodialysis and haemodiafiltration.在血液透析和血液透析滤过过程中保留有益分子和凝血因子。
Sci Rep. 2019 Apr 23;9(1):6370. doi: 10.1038/s41598-019-42783-w.
5
Revisiting the Pharmacology of Unfractionated Heparin.重新审视未分级肝素的药理学。
Clin Pharmacokinet. 2019 Aug;58(8):1015-1028. doi: 10.1007/s40262-019-00751-7.
6
How Robust Is the Mechanism of Folding-Upon-Binding for an Intrinsically Disordered Protein?折叠结合机制对于一个无序蛋白质有多稳健?
Biophys J. 2018 Apr 24;114(8):1889-1894. doi: 10.1016/j.bpj.2018.03.017.
7
Cooperative Interactions of Three Hotspot Heparin Binding Residues Are Critical for Allosteric Activation of Antithrombin by Heparin.三个热点肝素结合残基的协同相互作用对肝素介导的抗凝血酶变构激活至关重要。
Biochemistry. 2018 Apr 17;57(15):2211-2226. doi: 10.1021/acs.biochem.8b00216. Epub 2018 Mar 30.
8
Understanding the mechanism of binding between Gab2 and the C terminal SH3 domain from Grb2.了解Gab2与Grb2的C末端SH3结构域之间的结合机制。
Oncotarget. 2017 Jul 18;8(47):82344-82351. doi: 10.18632/oncotarget.19323. eCollection 2017 Oct 10.
9
Induced Fit Is a Special Case of Conformational Selection.诱导契合是构象选择的一种特殊情况。
Biochemistry. 2017 Jun 6;56(22):2853-2859. doi: 10.1021/acs.biochem.7b00340. Epub 2017 May 22.
10
Discrimination between conformational selection and induced fit protein-ligand binding using Integrated Global Fit analysis.使用综合全局拟合分析区分构象选择和诱导契合的蛋白质-配体结合
Eur Biophys J. 2016 Apr;45(3):245-57. doi: 10.1007/s00249-015-1090-1. Epub 2015 Nov 4.